Article Information
History
- September 27, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- César Augusto Trinta Weber, MD. MSc. PhD.1,*,
- Ingridi Teixeira Monteiro, MD.2,
- Julia Medeiros Gehrke, MD.2 and
- Wagner Silva de Souza, MD. MSc.2,3
- 1Medical Psychiatrist and Post-doctorate/Department of Neuroscience and Behavioral Sciences at Ribeirão Preto Medical School, USP. Scientific Director, Supervisor and advisor of the Psychiatry Training Program at the Jose de Barros Falcão Study Center, Porto Alegre, RS, Brazil. https://orcid.org/0000-0002-3499-3632
- 2Psychiatry Training Program, Jose de Barros Falcão Study Center, Porto Alegre, RS, Brazil.
- 3Master in Psychanalysis/John F Kennedy University Argentina.
- ↵*Corresponding author César Augusto Trinta Weber, MD. MSc. PhD. 190 Ecoville Avenue, House nº 07, Porto Alegre/RS Zip code: 91150-400, Brasil. trintaweber{at}hotmail.com
Posted September 27, 2020.
The Use of Psychoactive Substances in the Context of the Covid-19 Pandemic in Brazil
